Bifogade filer
PDF
Kurs
-6,27%
Kurs
-6,27%
Open
137,00
High
141,80
Low
123,90
Close
127,00
Kursutveckling under dagen för detta pressmeddelande
(SEK).
Likviditet
40,9 MSEK
Likviditet
40,9 MSEK
Rel. mcap
0,14%
Antal aktier
314 806
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2026-01-29 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-16 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | N/A | Årsstämma |
| 2025-04-16 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-01-30 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-17 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | X-dag ordinarie utdelning VITR 1.00 SEK |
| 2024-04-25 | - | Årsstämma |
| 2024-04-18 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-02 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | X-dag ordinarie utdelning VITR 0.85 SEK |
| 2023-04-27 | - | Årsstämma |
| 2023-04-21 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-24 | - | X-dag bonusutdelning VITR 7 |
| 2023-02-02 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | X-dag ordinarie utdelning VITR 0.80 SEK |
| 2022-04-27 | - | Årsstämma |
| 2022-04-22 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-10-20 | - | Extra Bolagsstämma 2021 |
| 2021-07-15 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | X-dag ordinarie utdelning VITR 0.80 SEK |
| 2021-04-28 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-10 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-16 | - | X-dag ordinarie utdelning VITR 0.00 SEK |
| 2020-06-15 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | - | Bokslutskommuniké 2019 |
| 2019-11-06 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-12 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | - | X-dag ordinarie utdelning VITR 0.85 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-04-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | - | Bokslutskommuniké 2018 |
| 2018-11-06 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-13 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | Split VITR 1:5 |
| 2018-04-27 | - | X-dag ordinarie utdelning VITR 3.70 SEK |
| 2018-04-26 | - | Årsstämma |
| 2018-04-24 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-11-02 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-14 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-28 | - | X-dag ordinarie utdelning VITR 2.60 SEK |
| 2017-04-27 | - | Årsstämma |
| 2017-04-25 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-09 | - | Bokslutskommuniké 2016 |
| 2016-11-03 | - | Kvartalsrapport 2016-Q3 |
| 2016-09-20 | - | Kapitalmarknadsdag 2016 |
| 2016-07-15 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-29 | - | X-dag ordinarie utdelning VITR 2.40 SEK |
| 2016-04-28 | - | Årsstämma |
| 2016-04-26 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-05 | - | Bokslutskommuniké 2015 |
| 2015-11-05 | - | Kvartalsrapport 2015-Q3 |
| 2015-07-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | - | X-dag ordinarie utdelning VITR 1.50 SEK |
| 2015-05-05 | - | Årsstämma |
| 2015-04-28 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-06 | - | Bokslutskommuniké 2014 |
| 2014-11-06 | - | Kapitalmarknadsdag 2014 |
| 2014-11-06 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-06 | - | Analytiker möte 2014 |
| 2014-07-11 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-06 | - | X-dag ordinarie utdelning VITR 1.00 SEK |
| 2014-05-05 | - | Årsstämma |
| 2014-04-23 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-06 | - | Bokslutskommuniké 2013 |
| 2013-11-11 | - | Kapitalmarknadsdag 2013 |
| 2013-11-07 | - | Kvartalsrapport 2013-Q3 |
| 2013-11-07 | - | Analytiker möte 2013 |
| 2013-07-12 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-30 | - | X-dag ordinarie utdelning VITR 0.60 SEK |
| 2013-04-29 | - | Årsstämma |
| 2013-04-19 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-13 | - | 15-7 2013 |
| 2013-02-07 | - | Bokslutskommuniké 2012 |
| 2012-11-01 | - | Kvartalsrapport 2012-Q3 |
| 2012-11-01 | - | Analytiker möte 2012 |
| 2012-09-24 | - | Extra Bolagsstämma 2012 |
| 2012-07-13 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-20 | - | X-dag ordinarie utdelning VITR 0.60 SEK |
| 2012-04-19 | - | Årsstämma |
| 2012-04-19 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-07 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-07-14 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | - | X-dag ordinarie utdelning VITR 0.60 SEK |
| 2011-04-27 | - | Årsstämma |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-09 | - | Bokslutskommuniké 2010 |
| 2010-11-02 | - | Kvartalsrapport 2010-Q3 |
| 2010-07-15 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-27 | - | Kvartalsrapport 2010-Q1 |
| 2010-04-27 | - | X-dag ordinarie utdelning VITR 0.50 SEK |
| 2010-04-26 | - | Årsstämma |
| 2010-02-05 | - | Bokslutskommuniké 2009 |
| 2009-11-03 | - | Kvartalsrapport 2009-Q3 |
| 2009-07-15 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-28 | - | X-dag ordinarie utdelning VITR 0.40 SEK |
| 2009-04-27 | - | Årsstämma |
| 2009-04-27 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2023-10-27 08:00:00
Third quarter
- Sales of SEK 848 (798) million, an increase of 6%, or 7% excluding discontinued business. In local currencies the growth was 2% and excluding discontinued business 3%.
- Sales, in local currencies and excluding discontinued business, increased by 5% in APAC and 14% in EMEA, while Americas decreased by 8%.
- Sales, in local currencies and excluding discontinued business, increased by 8% in Consumables and 14% in Technologies, while Genetic Services decreased by 5%.
- Gross margin increased to 55.7% (53.6).
- Operating income before depreciation and amortisation (EBITDA) was SEK 287 (276) million, giving an EBITDA margin of 33.9% (34.5). The EBITDA is stronger given the non-recurring income for the quarter last year.
- Operating cash flow increased to SEK 214 million (200).
- Net income increased to SEK 122 (108) million, resulting in earnings per share of SEK 0.90 (0.80).
First nine months
- Sales of SEK 2,607 (2,379) million, an increase of 10%, or 11% excluding discontinued business. In local currencies, growth was 4% and excluding discontinued business 5%.
- Sales, in local currencies and excluding discontinued business, increased by 15% in APAC and 6% in EMEA, while Americas decreased by 3%.
- Sales, in local currencies and excluding discontinued business, increased by 12% in Consumables and 4% in Technologies, while Genetic Services decreased by 1%.
- Gross margin increased to 56.1% (55.3).
- Operating income before depreciation and amortisation (EBITDA) was SEK 842 (777) million. Adjusted for non-recurring costs, EBITDA was SEK 868 (777) million, giving an EBITDA margin of 33.3% (32.6).
- Operating cash flow increased to SEK 586 million (470).
- Net income increased SEK 328 (321) million, resulting in earnings per share of SEK 2.42 (2.36).
Gothenburg, October 27, 2023
VITROLIFE AB (publ)
Bronwyn Brophy O'Connor, CEO
This disclosure contains information that Vitrolife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 27-10-2023 08:00 CET.
Contact:
Patrik Tolf, CFO, phone +46 (0) 31 766 90 21
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.